BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22694733)

  • 1. Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantation.
    Naesens M; Salvatierra O; Benfield M; Ettenger RB; Dharnidharka V; Harmon W; Mathias R; Sarwal MM;
    Am J Transplant; 2012 Oct; 12(10):2730-43. PubMed ID: 22694733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up.
    Sarwal MM; Ettenger RB; Dharnidharka V; Benfield M; Mathias R; Portale A; McDonald R; Harmon W; Kershaw D; Vehaskari VM; Kamil E; Baluarte HJ; Warady B; Tang L; Liu J; Li L; Naesens M; Sigdel T; Waskerwitz J; Salvatierra O
    Am J Transplant; 2012 Oct; 12(10):2719-29. PubMed ID: 22694755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study.
    Nehus EJ; Liu C; Lu B; Macaluso M; Kim MO
    Nephrol Dial Transplant; 2017 Aug; 32(8):1424-1431. PubMed ID: 28810723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocol.
    Mehta R; Bhusal S; Randhawa P; Sood P; Cherukuri A; Wu C; Puttarajappa C; Hoffman W; Shah N; Mangiola M; Zeevi A; Tevar AD; Hariharan S
    Am J Transplant; 2018 Jul; 18(7):1710-1717. PubMed ID: 29247472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of steroid-avoidance protocols in pediatric kidney transplant recipients.
    Nehus E; Goebel J; Abraham E
    Am J Transplant; 2012 Dec; 12(12):3441-8. PubMed ID: 22994143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.
    Nematalla AH; Bakr MA; Gheith OA; Elagroudy AE; Elshahawy el-M; Aghoneim M
    Exp Clin Transplant; 2007 Dec; 5(2):673-9. PubMed ID: 18194120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation.
    Sarwal MM; Yorgin PD; Alexander S; Millan MT; Belson A; Belanger N; Granucci L; Major C; Costaglio C; Sanchez J; Orlandi P; Salvatierra O
    Transplantation; 2001 Jul; 72(1):13-21. PubMed ID: 11468528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.
    Li L; Chang A; Naesens M; Kambham N; Waskerwitz J; Martin J; Wong C; Alexander S; Grimm P; Concepcion W; Salvatierra O; Sarwal MM
    Am J Transplant; 2009 Jun; 9(6):1362-72. PubMed ID: 19459814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation.
    Seifert ME; Yanik MV; Feig DI; Hauptfeld-Dolejsek V; Mroczek-Musulman EC; Kelly DR; Rosenblum F; Mannon RB
    Am J Transplant; 2018 Sep; 18(9):2189-2199. PubMed ID: 29766640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
    Sarwal MM; Vidhun JR; Alexander SR; Satterwhite T; Millan M; Salvatierra O
    Transplantation; 2003 Nov; 76(9):1331-9. PubMed ID: 14627912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid avoidance or withdrawal for kidney transplant recipients.
    Pascual J; Zamora J; Galeano C; Royuela A; Quereda C
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005632. PubMed ID: 19160257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid withdrawal in renal transplantation.
    Grenda R
    Pediatr Nephrol; 2013 Nov; 28(11):2107-12. PubMed ID: 23288351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology.
    Stevens RB; Foster KW; Miles CD; Kalil AC; Florescu DF; Sandoz JP; Rigley TH; Malik T; Wrenshall LE
    PLoS One; 2015; 10(10):e0139247. PubMed ID: 26465152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
    Chakrabarti P; Wong HY; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Hakala TR; Fung JJ; Simmons RL; Starzl TE; Shapiro R
    Transplantation; 2000 Sep; 70(5):760-4. PubMed ID: 11003353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical impact of humoral immunity in pediatric renal transplantation.
    Chaudhuri A; Ozawa M; Everly MJ; Ettenger R; Dharnidharka V; Benfield M; Mathias R; Portale A; McDonald R; Harmon W; Kershaw D; Vehaskari VM; Kamil E; Baluarte HJ; Warady B; Li L; Sigdel TK; Hsieh SC; Dai H; Naesens M; Waskerwitz J; Salvatierra O; Terasaki PI; Sarwal MM
    J Am Soc Nephrol; 2013 Mar; 24(4):655-64. PubMed ID: 23449533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of 6-month protocol renal biopsy under modern immunosuppression.
    Yango A; Gohh R; Wang LJ; Morrissey P; Shih M; Lowery K; Charpentier K; Gautam A; Mendonca C; Kumar S; Dworkin L; Monaco A
    Clin Nephrol; 2008 Dec; 70(6):490-5. PubMed ID: 19049705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil versus azathioprine in kidney transplant recipients on steroid-free, low-dose cyclosporine immunosuppression (ATHENA): A pragmatic randomized trial.
    Ruggenenti P; Cravedi P; Gotti E; Plati A; Marasà M; Sandrini S; Bossini N; Citterio F; Minetti E; Montanaro D; Sabadini E; Tardanico R; Martinetti D; Gaspari F; Villa A; Perna A; Peraro F; Remuzzi G
    PLoS Med; 2021 Jun; 18(6):e1003668. PubMed ID: 34166370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the frequency of modifiable histological changes observed on surveillance biopsies in pediatric kidney allograft recipients.
    Odum JD; Kats A; VanSickle JS; Chadha V; Brewer B; Staggs VS; Warady BA
    Pediatr Nephrol; 2020 Nov; 35(11):2173-2182. PubMed ID: 32556543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.